Quick Answer
Atea Pharmaceuticals, Inc. reported Shares Outstanding of 78.13 million shares for fiscal year 2025.
Atea Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 78.13M | -7.5% |
| 2024 | 84.46M | +1.2% |
| 2023 | 83.44M | +0.2% |
| 2022 | 83.29M | +0.2% |
| 2021 | 83.10M | +0.8% |
| 2020 | 82.44M | +716.9% |
| 2019 | 10.09M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 78.13M | -7.5% | -3.7% |
| June 30, 2025 | 81.14M | -3.9% | -5.2% |
| March 31, 2025 | 85.58M | +1.6% | +1.3% |
| December 31, 2024 | 84.46M | +1.2% | +0.0% |
| September 30, 2024 | 84.46M | +1.2% | +0.0% |
| June 30, 2024 | 84.42M | +1.2% | +0.2% |
| March 31, 2024 | 84.22M | +1.0% | +0.9% |
| December 31, 2023 | 83.44M | +0.2% | +0.0% |
- Atea Pharmaceuticals, Inc. showed a decrease of -7.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Atea Pharmaceuticals, Inc.’s shares outstanding has grown by 674.2% (from 10.09 million shares to 78.13 million shares).
- The most recent figure is from Atea Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: